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DEVELOPMENT OF AN ALTITUDE DECOMPRESSION SICKNESS
MODEL. T.E. Scoggins*, _1, _D.H. Bauer and A.A. Pilmani#*.
Armstrong Laboratory, Brooks AFB TX 78235-5000 and 1KRUG Life
Sciences, San Antonio TX.
INTRODUCTION. Availability of a computer model which could
accurately predict the risk of altitude decompression sickness (DCS) for any
given hypobaric exposure would be a great improvement over current risk
assessment methods based on comparison of the planned mission profile
with data from previous, often dissimilar exposures. METHODS.
Equations for perfusion-limited inert gas exchange and bubble growth
were used to compute tissue ratio (TR) and bubble volume data for 12
exposure profiles between 9,000 and 30,000 ft for which experimental DCS
incidence data from 395 subjects had been previously collected. Three
parameters, TR, maximum bubble volume (Vm) and bubble volume at
onset of DCS (Vo), were linked with observed DCS incidence using the
Hill equation with coefficients determined by nonqinear regression
analysis. RESULTS. The TR and Vm models both predicted no DCS
correctly in 96% of the cases while the Vo model correctly predicted 80%.
The postive predictive capabilities were lower with the TR and Vm
models predicting 74% and the Vo model predicting 67% of the DCS cases
correctly. CONCLUSIONS. This approach shows promise as an objective
computer-based method for predicting altitude DCS risk. Refinement of
the algorithms based on additional experimental data should improve the
validity of the models.
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INTRAVEN(_JS P_[/JC_fXI_%B_ _MDLSIC_ VS. _IC _ IN
TR_%_T OF _ _C_R_RESSION SIC_RESS.
J. Sigenonok. * Wright State University School of Medicine.
J. Mulcare and A. Woodrow. Wright Patterson AFB, Dayton, OH.
INTRODUCTION_: Treatment of decumpression sickness (DCS) with
hyperbaric oxygen (HBO) uses the physical rationale of decreased
bubble size and increased bubble-to-tissue nitrogen gradient with
reccmpression and oxygen breathing. Intravenous perfluorocarbon
emulsions (PFC) are proposed as an alternate treatment, using the
physical rationale of increased nitrogen solubility in the dissol-
ving fluid. Previous studies have shown an efficacy of FFC in DCS
treatment, but none have compared such treatment with HBO.
METHODS: We subjected male Wistar rats to an insult dive (200 fsw x
75 nin, 6 rain ascent) followed by treatment with either intravenous
normal saline (35 ml/kg) and the Air Force hyperbaric treatment
table 6, or intravenous Fluosol (35 ml/kg) and 100% oxygen at 1
ATA. We noted mortality and open field behavioral indices (Opto-
Varimex, Col_nbus Inst_ts). RESULTS: Mortality was equal in
both treat/ne_t groups (HBO: 47%, n = 43; PFC: 36%, n = 39), though
similar to that observed in untreated ardmals in a pilot study.
Open field monitoring showed no differences in distance travelled,
time resting or ambulatory, and number of small movements, though
PFC-treated rats spent less time in "stereotypio" movements.
CONCLUSIONS: Although interpretation is limited by technical diffi-
culties, the efficacies of intravenous perfluorocarbon emulsion and
hyperbaric oxygen were comparable. A more concentrated fluoro-
carbon preparation may be more effective, since it would decrease
the fluid volume required to achieve a given fluorocrit.
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USE OF ECHO IMAGING IN DECOMPRESSION MODEL DEVELOPMENT. R.M.
Olson* A.A. Pilmanis*, and T.E. Scoqqins*. KRUG Life Sciences,
San Antonio, TX 78279-0644 and Brooks Air Force Base, TX 78235-
5000.
INTRODUCTION. A model which assesses the risk of decompression
sickness (DCS) associated with altitude exposures of various
profiles is needed. This paper describes how echo imaging
techniques can provide critical measurements, such as bubble size,
to support the development of a decompression model. METHODS.
Three healthy male subjects were exposed to a simulated altitude of
29,500 ft. They were monitored with the Hewlett Packard SONOS 1000
echo imaging system at two monitoring sites, the heart and the
inferior vena cava (IVC) as viewed through the liver. Consequently,
the hepatic veins and bile duct system were also observed. RESULTS.
Bubble size was found to be between 5 and I00 micra both in the IVC
and in the hepatic veins. The upper size limit was established by
IVC microbubble flotation rates. Size confirmation was provided by
observation of pressure-induced right ventricular bubble resolution.
Microbubbles were visualized in the gall bladder and hepatic veins
but not in the liver itself. Therefore hepatic tissue bubbles, if
they exist, are smaller than intravascular bubbles. This size range
was incorporated into the ongoing development of a decompression
model. CONCLUSIONS. Echo imaging is a powerful tool for DCS
research and model development.
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THE EFFECT OF DIFFEPJ_CES IN TIME TO DETECTION OF CIRCULATING
MICROBUBBLES ON THE RISK OF DECOMPRESSION SICKNESS. K.V. Kumar*,
J.H. Gilbert*, M.R. Powell, and J.M. Waliqora. KRUG Life Sciences*,
and NASA Johnson Space Center, Houston, TX 77058.
INTRODUCTION. Circulating microbubbles (CMB) are frequently
detected prior to the appearance of symptoms of Decompression Sick-
ness (DCS). It is difficult to analyze the effect of CMB on sympton_
due to differences in the time to detection of CMB. This paper uses
survival analysis models to evaluate the risk of symptoms in the
presence of CIMB. METHODS. Information on 81 exposures to an alti-
tude of 6,400 m (6.5 psi)-for a period of three hours, with simula-
ted extravehicular activities, was e_amined. The presence or absence
of CMB was included as a time-dependent covariate in the Cox propo-
rtional hazards regression model. Using this technique, the subgroup
of exposures with CIMB was analyzed further. RESULTS. Mean (S.D.)
times in minutes to onset of CMB and symptoms were 125 (63) and ]65
(33), respectively, following the three-hour exposures. The risk of
symptoms ( ]7/8] ) increased ]4 times in the presence of CMB, after
controlling for variations in time to detection of CMB. Further,
t_he risk was lower when time to detection of CMB was >60 minutes
(risk ratio=0.96; 95% confidence intervals=0.94-0.99; P<0.0] ), comp-
ared to CIMB detected before 60 minutes at altitude. CONCLUSIONS.
Survival analysis showed that individual risk of DCS changes signi-
ficantly due to variations in time to detection of CMB. This infor-
mation is important in evaluating the risk of DCS in the presence
of CMB.
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DECOMPRESSION SICKNESS PROTECTION USING A 100% OXYGEN
PRESSURE SUIT ENVIRONMENT. J. T. Webb*, KRUG Life
Sciences, San Antonio, TX 78279-0644 and A. A. Pilmanis*,
AL/CFTS, Brooks AFB, TX 78235-5000.
INTRODUCTION. Selection of the lowest safe pressure
for an extravehicular activity (EVA) suit which eliminates
the requirement for prebreathing depends on demonstrating
an acceptable risk of venous gas emboli (VGE; precordial
Doppler grades 3 and 4) and decompression sickness (DCS).
The EVA suit target pressure of 8.3 psia was set by NASA
several years ago based on results of breathing 50% oxygen
and 50% nitrogen during zero-prebreathe exposures. The
present work investigated the effects of zero-prebreathe
exposures at and below 8.3 psia while breathing 100%
oxygen. METHODS. Thirty male human subjects were exposed
for 6 hours, without prebreathing, to pressures of 8.3
(n=10), 7.8 (n=lO), and 7.3 (n=10) psia while performing
moderate exercise. Subjects were monitored for
Doppler-detected VGE using Hewlett-Packard SONOS systems
and observed for DCS symptoms. RESULTS. No cases of DCS
were present at 8.3, 7.8, or 7.3 psia. Grade 3 or 4 VGE
were not detected at 8.3 psia but were present during 10%
and 20% of the exposures at 7.8 and 7.3 psia respectively.
CONCLUSION. EVA suit pressure with a 100% oxygen
environment could be established at 7.3 psia and maintain
lower DCS and VGE risk levels compared to an 8.3 psia suit
pressure with a 50% oxygen:50% nitrogen environment
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VARIABILITY IN HOFFMANN AND TENDON REFLEXES IN HEALTHY MALE
SUBJECTS. E. Good, S. DO, and k.t Jaweed*. Humana Hospital, Webster, TX; Baylor
College of Medicine, Houston, TX; and *NASA Johnson Space Center, Biomedical
Operations & Research Branch, Houston, TX 77058,
INTRODUCTION: There is a time dependent decrease in amplitude of H- and T-reflexes
during O-G exposure and subsequently an increase in the amplitude of the H-reflex 2-4 hrs
after return to 1-G environment, These alterations have been attributed to adaptation of
the human neurosensory system to gravity. The Hoffmann reflex (H-reflex) is an
acknowledged method to determine the integrity of the monosynaptic reflex arc. However,
deep tendon reflexes (DTR's or T-reflexes), elicited by striking the tendon also utilizes the
entire reflex arc. The objective of this study was to compare the variability in latency and
amplitude of the two reflexes in healthy subjects. MTH_.E_.T__.Q_D__:Nine healthy male subjects,
27-43 years in age, 161-175 cm in height plus 60-86 Kg in weight, underwent weekly testing
for four weeks with a Dan-Tec EMG counterpoint EMG system (Dan Tec, Inc., Denmark).
Subjects were studied prone and surface EMG electrodes were placed on the right and left
soleus muscles. The H-reflex was obtained by stimulating the tibial nerve in the politeal
fossa with a 0.2 msec square wave pulses delivered at 2 Hz until the maximum H-reflex
was obtained. The T-reflex was evoked by tapping the achilles tendon with a self-trigger-
ing reflex hammer connected to the EMG system. The latencies and amplitudes for the H-
and T-reflexes were measured. _: These data indicate that the amplitudes of
these reflexes varied considerably. However, latencies to evoked responses were consis-
tent. The latency of the T-reflex was approximately 3-5 msec longer than the H-reflex.
CONCLUSION: The T-reflex is easily obtained, requires less time, and is more comfort-
able to perform. Quantitative data can be obtained by deploying self-triggering, force
plated reflex hammer both in the 1-G and O-G environment.
tQWRI,_N._ PAGE
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POSTURAL EQUILIBRIUM TESTING OF AVIATORS: NORMATIVE
SCORES AND ADAPTATION EFFECTS, K.A.Baylor .1, B,J. McGrath *1,
S.M. Molstad 2, A.H. Rupert .1, and F.E. Guedry .3. 1Naval Aerospace Medical
Research Laboratory , Pensacola, FL, 2Northwestern State University, Natchitoches,
LA; and 3University of West Florida; Pensacola, FL.
INTRODUCTION An estimated 29% of aviators experience symptoms of
Simulator Sickness (SS) following simulator training. High]>' sensitive measures are
required to assess the aftereffects of simulator training on balance and coordination,
and the impact on performance and safety. The Neurocom Equitest System is a
clinical device that examines the interaction of vestibular, visual and proprioceptive
inputs on the balancing ability of subjects. The p_0ses of this study were to
develop a normative aviator database as compared _o. clinical norms, and to
determine learning effects from repeated test sessi0_i_ METHODS. Fifty=three male
and 33 female aviators were tested on an initial day using an Equitest System.
Repeat testing was completed on 19 males and 11 females on four additional days.
RESULTS. Sensory Organization Test (SOT) equilibrium scores for the aviators
were significantly higher than clinical norms. Equilibrium scores on the- first trial
were significantly lower than on the two subsequent trials. Differences between
males and females existed in a correlation between equilibrium and strategy scores.
A significant learning effect existed for equilibrium, with a plateau reached after3
days. Motor Coordination Test latency scores for male aviators were significantly
faster than frr females. CONCLUSiCJNS. The high aviator Scores demonstrate the
importance of establishing population-specific norms for balance research. Gender
differences among the aviators on :latency scores support previous research
establishing similar differences in reaction time. The learning effects from repeated
SOT tests, which reduce the effectiveness of this device to assess SS aftereffects in
pre- and post-simulator testing, may be minimized with random-order trials.
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THE PSYCHOPHYSICAL FUNCTION FOR PERCEIVED
GRAVITATIONAL-INERTIAL FORCE DOES NOT DEPEND ON THE
ORIENTATION OF THE OTOLITH ORGANS. M. Cohen.* R. W_leh,*
and C. DeRoshi_*. NASA-Ames Research Center, Moffett Field, CA
94035.
INTRODUCTION. It has generally been believed that the perceived
intensity of a gravitationaMnertial force depends on both the
magnitude and orientation of the force with respect to the otolith
organs, as does the elevator illusion, In this study, we examine the
perceived intensity of Gz force and the elevator illusion as a function of
the applied force and the orientation of S's head. METHODS. Each of
eleven male Ss was seated upright in a: swinging chair mounted in the
Ames 20:G Human Centrifuge whil_ he Set a visual target to his
apparent horizon and judged the perceived intensity of Gz forces by
cross-modal matches on a hand dynamometer. Plateau Gz levels were
1.00, 1,25, 1,50, 2.00, 2:25, and 2.50; a 3G-second ramp to pIateau was
used in all cases, and the duration of exposure at each plateau was 120
seconds. All measures were obtained both with S's head erect and
pitched forward 30 degrees. _. Although the elevator illusion
changed with head orientation {F (6,60)= 7.56; p<0.001)}, the perceived
intensity of Gz was essentially the same for both orientations of the
head {F(6,60) = 0.61; p>,50}. CONCLUSIONS. The results of this
experiment suggest that the perceived intensity of gravitational-inertial
force does not depend on otolith mechanisms in the same way as does
the elevator illusion and that somesthetic, tactile, and other
proprioceptive inputs are important for the psychophysical function.
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THE VESTIBULO-OCULAR REFLEX AND OPTOKINETIC NYSTAGMUS
UNDER THE INFLUENCE OF CINNARIZINE. I. Doweck A.
Shupak, O. Spitzer, Y. Melamed and C.R. Gordon*.
Motion Sickness and Human Performance Laboratory,
Israeli Naval Hyperbaric Institute, Haifa, ISRAEL.
INTRODUCTION. Cinnarizine (Cn) is an antihistaminic
agent with specific vestibular Ca++ channel blocking
capacity, which has been found effective as an anti-
motion sickness drug. We used the Vestibulo-ocular
reflex (VOR) and the optokinetic nystagmus (OKN) to
evaluate Cn's effects on the eye movement control
mechanism. METHODS. The VOR parameters were
evaluated using the Smooth Harmonic Acceleration Test
(SHA) at 5 frequencies: O.Oi-O.16 Hz. The OKN was also
evaluated using a sinusoidal rotatory pattern at 3
frequencies: 0.01-0.04 Hz. The study was conducted on 16
healthy subjects aged 18-22. The effects of On 50 mg vs
placebo were compared using a double-blind, randomized,
crossover design 2 hours after drug administration. All
16 subjects underwent the SHA test, but only 12
completed the OKN test. RESULTS. Under the influence
of Cn 50 mg, VOR gain at 0.04 HZ and phase lead at 0.16
HZ were significantly lower, while on the OKN test,
phase leadivaIues were higher at 0.01 Hz. CONCLUSIONS.
On 50 mg partially affects both VOR and OKN parameters.
The drug's influence on the OKN's phase parameter
suggests that On affects the oculomotor pathways as well
as the vestibular end organ.
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MOTION SICKNESS INVESTIGATION: THE CHOICE OF TREATMENT?
I.A. Niehioomk. LLL_._- Institute for Biomedical Problems,
Moscow, USSR.
INTRODUCTION. In spite of successful treated motion
sickness (MS) episodes during space flights, this problem
remains actual until its pathogeny will be clear.
M.F,TJiQD._. More than 100 various susceptible to laboratory induced MS
male volunteers were examined by electro-physiological and radioimmune
assay methods for estimation of central nerve system (CNS) activity and
blood concentration of pituitary-adrenal, thyroid, pancreatiu, and vasoactive
hormones. Some energy metabolism substrates (EMS) were determined
in brain structures during MS simulating animal experiments. Various drags
have been used for MS treatment. _. MS induced reactions
expressed stress-associated hormones blood excess followed CNS
excitation, and blood EMS increase for its easy delivery to brain structures.
All drugs while being effective in MS treatment, significantly decreased
CNS activity, accompanied with reduced endocrine and metabolic
changes. CONCLUSION. Our data evidence fhat any effective
pharmacological MS treatment probably would: result in physical and
psychologiCal activity depression which could complicate flight program
success. Therefore, no-drug MS countermeasures, or drug-induced
adaptive reactions increase would be prefered.
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USE OF INJECTABLE PROMETHAZINE TO DECREASE SYMPTOM
SCORES OF SPACE MOTION SICKNESS. B.G. BECK. M.D.*
A.E. NICOGOSSIAN, M.ID,* MEDICAL OPERATIONS BRANCH, NASA-
JSC, HOUSTON, TX 77058
Introdul;:tlon. Space Motion Sickness (SMS) has been a problem
affecting approximately 74% of first-time Shuttle flyers. Promethazine
injections have been used for 29 cases of SMS to decrease the severity
of their illness. Although reported to be effective in reducing symptoms
in 27 of the 29 cases, there has been no proof of its efficacy. Methods.
Retrospective analyses of Medical Debriefs examining the symptom
scores for nausea, vomiting, decreased appetite, and stomach
awareness were performed. Each symptom is rated on a mild=l,
moderate=2, severe=3 system for each flight day. Crewmember scores
from the first three flight days on an initial flight in which injectable
promethazine had not been used were compared to scores in a later
flight in which the promethazine was utilized. Scores were also
compared in a similar group of crewmembers who did not use
promethazine. Flesuffs. There was a decrease in median scores for
all symptoms except nausea, however it was significant (p=.014) only for
the vomiting scores. This significant decrease was not seen in the
control group. Conclusions. Injectable promethazine has been
associated with a significant decrease in vomiting compared to earlier
flights in which injectable promethazine was not used.
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HEMODYNAMIC MEASUREMENTS DUPdNG PARABOLIC FLIGHT
A. Miyamoto* _ K. Suzuki S. Kaneko S. Watanabe*, S. Usui J_..
Nakavarn_
National Space Development Agency of Japan, Nagoya University, Toyohashi
University of Technology, Toray Research Center.
INTRODUCTION. A parabolic flight is a useful method as a simulation of
weightlessness to study cardiovascular deconditioning, even though the available
time is very short.
METHODS. Cardiac output and blood pressure were continuously monitored
during parabolic flights performed by a small rear-jet aircraft (MU 300).
A male subject, 28 years old, took 9 to 11 parabolic flights a day for 6 days.
Two accelerating patterns, 2.5-G and 1.3-G level, were used. Cardiac output
was measured by impedance cardiography and blood pressure was measured by
a finger pressure cuff method. The positions of the subject were sitting up
straight and sitting reclined.
RESULTS. Heart rate increased by 25% at 2.3-G accelerating period and
decreased by 10% during low G period in the sitting up position. Stroke
volume decreased by 30% at 2.3-G entry and increased by 30% during low G
period. These changes became less in the 1.3-G pattern and in the sitting
reclined position too. Diastolic blood pressure decreased during low G period.
The subject seemed adapted in the latter parabolas in the same day.
CONCLUSION. These results suggested that the hemodynamic changes in
the parabolic flight would be modified by the pattern of acceleration and
adaptation of the subject.
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